PMN (ProMIS Neurosciences) FCF Margin %: 0.00% (As of Mar. 2026)

What is ProMIS Neurosciences FCF Margin %?

ProMIS Neurosciences PMN +22.42% 30 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates PMN with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 957 Biotechnology companies, ProMIS Neurosciences ranks worse than 104493.1% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ProMIS Neurosciences's Free Cash Flow for the three months ended in Mar. 2026 was $-12.38 Mil. ProMIS Neurosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, ProMIS Neurosciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, ProMIS Neurosciences's current FCF Yield % is -30.14%.

The historical rank and industry rank for ProMIS Neurosciences's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of ProMIS Neurosciences was -56650.00%. The lowest was -466200.00%. And the median was -222325.00%.

PMN's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

ProMIS Neurosciences FCF Margin % Related Terms

ProMIS Neurosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for ProMIS Neurosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProMIS Neurosciences FCF Margin % Chart

ProMIS Neurosciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

0.00

ProMIS Neurosciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PMN vs BMEA, ANIX, ATRA: FCF Margin % Comparison

For the Biotechnology subindustry, ProMIS Neurosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProMIS Neurosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProMIS Neurosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ProMIS Neurosciences's FCF Margin % falls into.

Save Embed

30GF Score

ProMIS Neurosciences Inc PMN

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ProMIS Neurosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ProMIS Neurosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-28.119	/	0
	=	%

ProMIS Neurosciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-12.384	/	0
	=	%

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of 0.00% mean?

ProMIS Neurosciences (PMN) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ProMIS Neurosciences and its competitors. According to the industry distribution chart, ProMIS Neurosciences ranks #999999 out of 957 companies in the Biotechnology industry.

Is ProMIS Neurosciences' FCF Margin % too high?

ProMIS Neurosciences' current FCF Margin % is 0.00%. Based on the distribution chart, ProMIS Neurosciences ranks #999999 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ProMIS Neurosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does ProMIS Neurosciences' FCF Margin % compare to BMEA and ANIX?

According to the Biotechnology industry distribution chart, ProMIS Neurosciences ranks #999999 out of 957 companies for FCF Margin %. This places ProMIS Neurosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ProMIS Neurosciences and its competitors. ProMIS Neurosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ProMIS Neurosciences stock overvalued right now?

ProMIS Neurosciences (PMN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. ProMIS Neurosciences' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For ProMIS Neurosciences (PMN), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProMIS Neurosciences Business Description

Industry Healthcare Biotechnology

Comparable Companies BMEA ANIX ATRA BDTX CSBR SEER RLYB CGTX FBIO INO VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 23J:Germany

Address 1920 Yonge Street, Suite 200, Toronto, ON, CAN, M4S 3E2

Website https://www.promisneurosciences.com

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

30GF Score

Get the complete analysis for PMN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.39

Price

View PMN Analysis

See FCF Margin % data for all stocks →